FierceVaccines

Overview: Examines the people, trends and research projects making news in the vaccine field.

Newsletter Subscribers: 20,000+

Publishing Schedule: weekly

Audience: Senior pharmaceutical and biotech executives, researchers, and others focused on developing the vaccines of the future.

Reader Demographics

73% of readers have recommended or forwarded FierceVaccines to a colleague

87% of readers rank the quality of FierceVaccines as 4 stars or above

Job Function
Corporate Management (CEO, CFO, COO, CIO, SVP, VP) - 21%
Research & Development - 21%
Regulatory / Quality (QA/QC) - 7%
Business Development - 11%
Manufacturing and Operations - 4%
Marketing and Sales - 13%
Corporate Operations (Legal, Finance, IT, HR, Other) - 7%
Academic - 6%
Other - 9%

Type of Company
Pharmaceutical - 23%
Biotechnology - 27%
Academia / Government Research / Other Research - 12%
Service Org (CMO, CRO, CSO, Contract Packaging, other) - 9%
Consulting - 15%
Marketing / Media - 3%
Finance / PE / VC - 3%
Other - 7%

Region
North America - 76%
Europe - 16%
Asia-Pacific - 4%
Other - 3%

64% of readers supervise others

59% make purchasing decisions or manage a budget